Download PDF
Exp Clin Endocrinol Diabetes 2023; 131(06): 319-337
DOI: 10.1055/a-1946-3878
German Diabetes Association: Clinical Practice Guidelines

Diabetes and Migration

Sebahat Şat
1   MVZ DaVita Rhine-Ruhr, Düsseldorf, Germany
2   German Diabetes Association (DDG) Working Group on Diabetes and Migrants
,
Kadriye Aydınkoç-Tuzcu
2   German Diabetes Association (DDG) Working Group on Diabetes and Migrants
3   Wilhelminenspital of the City of Vienna, 5th Medical Department of Endocrinology, Rheumatology and Acute Geriatrics, Vienna, Austria
4   Austrian Diabetes Association (ÖGD) Working Group on Migration and Diabetes
,
Faize Berger
2   German Diabetes Association (DDG) Working Group on Diabetes and Migrants
,
Alain Barakat
2   German Diabetes Association (DDG) Working Group on Diabetes and Migrants
5   Diabetes Center Duisburg-Mitte (DZDM), Duisburg, Germany
,
Ina Danquah
2   German Diabetes Association (DDG) Working Group on Diabetes and Migrants
6   Heidelberg Institute of Global Health (HIGH), Medical Faculty and University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany
,
Karin Schindler
4   Austrian Diabetes Association (ÖGD) Working Group on Migration and Diabetes
7   Medical University of Vienna, Department of Internal Medicine III, Clinical Department of Endocrinology and Metabolism, Vienna, Austria
,
Peter Fasching
3   Wilhelminenspital of the City of Vienna, 5th Medical Department of Endocrinology, Rheumatology and Acute Geriatrics, Vienna, Austria
4   Austrian Diabetes Association (ÖGD) Working Group on Migration and Diabetes
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints
Notice of update

The DDG practice recommendations are updated regularly during the second half of the calendar year. Please ensure that you read and cite the respective current version.

Updates To Content And Different Recommendations Compared To The Previous Year’s Version

Recommendation 1:

Update of data on the population group with a migration background (see point 1.3 Demographics for Germany).

Reason:

There is more recent data on demographics for Germany.

Supporting references:

[9] [11]

Recommendation 2:

Data from 2019 show that the use of systems for continuous glucose monitoring (CGM) is 30 % more common in patients without a migration background than in those with a migration background [41] (see point 1.7.2 Particularities in the therapy).

Reason:

New insights into the use of digital supporting tools in diabetes therapy and blood glucose control.

Supporting references:

[38]

Recommendation 3:

Update of the effectiveness of common diabetes medications such as alpha-glucosidase inhibitors (acarbose) and insulin.

Reason:

New findings on the effectiveness of common diabetes drugs in people of non-European origin.

Supporting references:

[42]

Recommendation 4:

New data on the increasing use of online translation services in healthcare (see point 1.8.2 Language)

Reason:

The importance of online translation services is also growing in healthcare and diabetes treatment for people with migration experience.

Recommendation 5:

Prevention of diabetes mellitus and its secondary diseases were included (see point 1.11 Prevention)

Reason:

To date, the therapeutic approaches and specificities of diabetes mellitus in people of non-German origin have mainly been discussed. The revised edition now also takes into account the prevention of diabetes mellitus and its complications.

Recommendation 6:

Expansion and updating of the topic of fasting in people with type 1 diabetes (see point 1.13 Ramadan – One Month of Fasting)

Reason:

New insights into the possibility of fasting in people with type 1 diabetes mellitus and with the help of certain drug regimens.

Supporting references:

[93] [97]

The practical recommendation “Diabetes and Migration” of the German Diabetes Association (DDG) was prepared for the first time and in cooperation with the Austrian Diabetes Association (ÖDG). The practice recommendation is intended to supplement the existing guidelines on diabetes mellitus and provides practical recommendations for the diagnosis, therapy and care of people with diabetes mellitus who come from different linguistic and cultural backgrounds.



Publication History

Article published online:
14 June 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Migration-Integration/Methoden/migrationshintergrund.html?nn=208952
    PubMed
  • 2 Robert Koch-Institut Hrsg. Gesundheit in Deutschland. Gesundheitsberichtserstattung des Bundes. Gemeinsam getragen von RKI und Destatis. Berlin: RKI; 2015
    Google Scholar
  • 3 Berger F. Typ-2-Diabetes und Migranten: Menschen aus verschiedenen Sprach- und Kulturräumen. Diabetologie 2018; 13: 241-255
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Hundenbom J, Enderer J. Die Neuregelung des Mikrozensus ab 2020. Statistisches Bundesamt WISTA 2019; 6: 9-17 Artikelnummer: 1010200-19006-4
    PubMedGoogle Scholar
  • 5 Statistisches Bundesamt, Wiesbaden. Pressemitteilung Nr. 162 vom 12. April 2022. Received from: https://www.destatis.de/DE/Presse/Pressemitteilungen/2022/04/PD22_162_125.html; Accessed: 16.04.2022
    PubMed
  • 6 Statistisches Bundesamt (Destatis), 2022. Bevölkerung und Erwerbstätigkeit (Bevölkerung mit Migrationshintergrund Ergebnisse des Mikrozensus 2021. Received from: https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Migration-Integration/Publikationen/Downloads-Migration/migrationshintergrund-2010220217004.pdf?__blob=publicationFile; Accessed 16.04.2022
    PubMed
  • 7 Jacobs E, Rathmann W. Epidemiologie des Diabetes. Diabetologie 2017; 12: 437-446
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Tenkorang EY. Early onset of type 2 diabetes among visible minority and immigrant populations in Canada. Ethn Health 2017; 22: 266-284
    CrossrefPubMedGoogle Scholar
  • 9 Aydinkoc K et al. Diabetesprävalenz und Diabetes-spezifisches Wissen bei türkischen MigrantInnen. ÖDG-Herbsttagung 2011, p. 28. Received from: unter www.oedg.at/pdf/1111_OEDG_JT_Programm.pdf; Accessed: 11.06.2018
    PubMed
  • 10 Meeks KA, Freitas-Da-Silva D, Adeyemo A. et al. Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med 2016; 11: 327-340
    CrossrefPubMedGoogle Scholar
  • 11 Ujcic-Voortman JK, Schram MT, Jacobs-van der Bruggen MA. et al. Diabetes prevalence and risk factors among ethnic minorities. Eur J Public Health 2009; 19: 511-515
    CrossrefPubMedGoogle Scholar
  • 12 Stirbu I, Kunst AE, Bos V. et al. Differences in avoidable mortality between migrants and the native Dutch in The Netherlands. BMC Public Health 2006; 6: 78
    CrossrefPubMedGoogle Scholar
  • 13 Li X, Sundquist J, Zöller B. et al. Risk of hospitalization for type 2 diabetes in first- and second-generation immigrants in Sweden: a nationwide follow-up study. J Diabetes Complicat 2013; 27: 49-53
    CrossrefPubMedGoogle Scholar
  • 14 Vandenheede H, Deboosere P, Stirbu I. et al. Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change. Eur J Epidemiol 2012; 27: 109-117
    CrossrefPubMedGoogle Scholar
  • 15 Sivaprasad S, Gupta B, Gulliford MC. et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One 2012; 7: e32182
    CrossrefPubMedGoogle Scholar
  • 16 Reeske A, Zeeb H, Razum O. et al. Differences in the Incidence of Gestational Diabetes between Women of Turkish and German Origin: An Analysis of Health Insurance Data From a Statutory Health Insurance in Berlin, Germany (AOK), 2005-2007. Geburtshilfe Frauenheilkd 2012; 72: 305-310
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Austria Statistik. Österreichische Gesundheitsbefragung Bundesministerium für Soziales, Gesundheit, Pflege und Konsumentenschutz (BMSGPK). Wien 2019; 2020
    PubMedGoogle Scholar
  • 18 Schmutterer I, Delcour J, Griebler R, Hrsg. Österreichischer Diabetesbericht 2017. Wien: Bundesministerium für Gesundheit und Frauen; 2017
    PubMed
  • 19 International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium; 2021. Received from: https://www.diabetesatlas.org
    PubMed
  • 20 Aydinkoc K, Fasching P, Taskiran T et al. Diabetesprävalenz und Diabetes-spezifisches Wissen bei türkischen MigrantInnen. ÖDG-Herbsttagung 2011: 28. Im Internet: www.oedg.org/pdf/1111_OEDG_JT_Programm.pdf ; Accessed: 11.06.2018
    PubMed
  • 21 Bundesministerium für Gesundheit. Statistik A. Österreichische Gesundheitsbefragung 2006/2007. Familie und Jugend. Sozio-demografische und sozioökonomische Determinanten von Gesundheit. 2007
    PubMed
  • 22 Kirkcaldy B, Wittig U, Furnham A. et al. Migration und Gesundheit. Psychosoziale Determinanten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006; 49: 873-883
    CrossrefPubMedGoogle Scholar
  • 23 White JS, Hamad R, Li X. et al. Long-term effects of neighbourhood deprivation on diabetes risk: quasi-experimental evidence from a refugee dispersal policy in Schweden. Lancet Diabetes Endocrinol 2016; 4: 517-524
    CrossrefPubMedGoogle Scholar
  • 24 Statistik A. Österreichische Gesundheitsbefragung 2006/2007. Bundesministerium für Gesundheit, Familie und Jugend. Soziodemografische und sozioökonomische Determinanten von Gesundheit. 2007
    PubMedGoogle Scholar
  • 25 Schleicher E, Gerdes C, Petersmann A. et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2022; 130: S1-S8
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Unnikrishnan R, Anjana RM, Mohan V. Drugs affecting HbA1c levels. Indian J Endocrinol Metab 2012; 16: 528-531
    CrossrefPubMedGoogle Scholar
  • 27 Cohen RM, Haggerty S, Herman WH. HbA1c for the diagnosis of diabetes and prediabetes: Is it time for a mid-course correction?. J Clin Endocrinol Metab 2010; 95: 5203-5206
    CrossrefPubMedGoogle Scholar
  • 28 Hinzmann R, Schlaeger C, Tran CT. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes?. Int J Med Sci 2012; 9: 665-681
    CrossrefPubMedGoogle Scholar
  • 29 Florkowski C. HbA as a diagnostic test for diabetes mellitus – reviewing the evidence. Clin Biochem Rev 2013; 34: 75-84
    PubMedGoogle Scholar
  • 30 Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: Implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012; 97: 1067-1072
    CrossrefPubMedGoogle Scholar
  • 31 Zemlin AE, Matsha TE, Kengne AP. et al. Derivation and validation of an HbA1c optimal cutoff for diagnosing prediabetes in a South African mixed ancestry population. Clin Chim Acta 2015; 488: 215-219
    CrossrefPubMedGoogle Scholar
  • 32 Gordon DK, Hussain M, Kumar P. et al. The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability. Cureus 2020; 12: e9685
    PubMedGoogle Scholar
  • 33 Booth R, Jiang Y, Morrison H. et al. Ethnic dependent differences in diagnostic accuracy of glycated hemoglobin (HbA1c) in Canadian adults. Diabetes Res Clin Pract 2018; 143-149
    CrossrefPubMedGoogle Scholar
  • 34 Wheeler E, Leong A, Liu CT. et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med 2017; 14: e1002383
    CrossrefPubMedGoogle Scholar
  • 35 Klonoff DC. Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus. J Diabetes Sci Technol 2020; 14: 3-7
    CrossrefPubMedGoogle Scholar
  • 36 Weatherall DJ. The evolving spectrumof the epidemiology of thalassemia. Hematol Oncol Clinics North Am 2018; 32: 165-175
    CrossrefPubMedGoogle Scholar
  • 37 Mathur R, Farmer RE, Eastwood SV. et al. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study. PLoS Med 2020; 17: e1003106
    CrossrefPubMedGoogle Scholar
  • 38 Eberly LA, Yang L, Eneanya ND. et al. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US. JAMA Netw Open 2021; 4: e216139
    CrossrefPubMedGoogle Scholar
  • 39 Gerber C, Cai X, Lee J. et al. Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. Clin J Am Soc Nephrol 2018; 13: 884-892
    CrossrefPubMedGoogle Scholar
  • 40 Mathur R, Dreyer G, Yaqoob MM. et al. Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study. BMJ Open 2018; 8: e020145
    CrossrefPubMedGoogle Scholar
  • 41 Auzanneau M, Rosenbauer J, Maier W. et al. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics between 2016 and 2019 in Germany. J Diabetes Sci Technol 2021; 15: 1059-1068
    CrossrefPubMedGoogle Scholar
  • 42 Cai XL, Ji LN. Treatment response between Asian and non-Asian patients with type 2 diabetes: is there any similarity or difference?. Chin Med J 2019; 132: 1-3
    CrossrefPubMedGoogle Scholar
  • 43 Rashid M, Shahzad M, Mahmood S. Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus. Pak J Med Sci 2019; 35: 1-76
    CrossrefPubMedGoogle Scholar
  • 44 Ito Y, Ambe K, Kobayashi M. et al. Ethnic difference in the pharmacodynamics-efficacy relationship of dipeptidyl peptidase-4 inhibitors between Japanese and non-Japanese patients: a systematic review. Clin Pharmacol Ther 2017; 102: 701-708
    CrossrefPubMedGoogle Scholar
  • 45 Kim YG, Hahn S, Oh J. et al. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis. Diabetes Obes Metab 2014; 16: 900-909
    CrossrefPubMedGoogle Scholar
  • 46 Geiser JS, Heathman MA, Cui X. et al. Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials. Clin Pharmacokinet 2016; 55: 625-634
    CrossrefPubMedGoogle Scholar
  • 47 DeSouza C, Cariou B, Garg S. et al. Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials. J Clin Endocrinol Metab 2020; 105: dgz072
    CrossrefPubMedGoogle Scholar
  • 48 Scheen AJ. SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients. Diabetes, metabolic syndrome and obesity: targets and therapy 2020; 13: 2765-2779
    CrossrefPubMedGoogle Scholar
  • 49 Urs-Vito A, von Jan U, Pramann O. Dolmetscher-Apps im Patientengespräch – Talk per Touch. Dtsch Arztebl 2013; 1: 26-28
    PubMedGoogle Scholar
  • 50 Jaiteh M, Cormi C, Hannetel L. et al. Perception of the use of a telephone interpreting service during primary care consultations: A qualitative study with allophone migrants. PloS One 2022; 17: e0264832
    CrossrefPubMedGoogle Scholar
  • 51 Diker O, Deniz T, Çetinkaya A. History of Turkish Cuisine Culture and the Influence of the Balkans. IOSR Journal of Humanities And Social Science 2016; 21: 01-06
    PubMedGoogle Scholar
  • 52 Schmid B. Ernährung und Migration, Empirische Untersuchungen zum Ernährungsverhalten italienischer, griechischer und türkischer Migrantinnen in Deutschland. München: Herbert UTZ Verlag;; 2003
    Google Scholar
  • 53 Galbete C, Nicolaou M, Meeks KA. et al. Food consumption, nutrient intake, and dietary patterns in Ghanaian migrants in Europe and their compatriots in Ghana. Food Nutr Res 2017; 61: 1341809
    CrossrefPubMedGoogle Scholar
  • 54 Magni P, Bier DM, Pecorelli S. et al. Perspective: Improving Nutritional Guidelines for Sustainable Health. Advances in Nutrition 2017; 8: 532-545
    PubMedGoogle Scholar
  • 55 Amoah S, Enin R, Sagoe K. et al. Feasibility of a culturally adapted dietary weight-loss intervention among Ghanaian Migrants in Berlin, Germany: The ADAPT Study. Int J Environ Res Public Health 2021; 18: 510
    CrossrefPubMedGoogle Scholar
  • 56 Mora N, Golden SH. Understanding Cultural Influences on Dietary Habits in Asian, Middle Eastern, and Latino Patients with Type 2 Diabetes: A Review of Current Literature and Future Directions. Curr Diab Rep 2017; 17: 126
    CrossrefPubMedGoogle Scholar
  • 57 Breuing J, Joisten C, Neuhaus AL. et al. Communication strategies in the prevention of type 2 diabetes and gestational diabetes in vulnerable groups: a scoping review. Syst Rev 2021; 10: 301
    CrossrefPubMedGoogle Scholar
  • 58 Hadziabdic E, Pettersson S, Marklund H. et al. Development of a groupbased diabetes education model for migrants with type 2 diabetes, living in Sweden. Prim Health Care Res Dev 2020; 21: e50
    CrossrefPubMedGoogle Scholar
  • 59 Rawal L, Sahle BW, Smith BJ. et al. Lifestyle interventions for type 2 diabetes management among migrants and ethnic minorities living in industrialized countries: a systematic review and meta-analyses. BMJ Open Diabetes Res Care 2021; 9: e001924
    CrossrefPubMedGoogle Scholar
  • 60 Weiss C, Oppelt P, Mayer RB. The participation rate ofmigrant women in gestational diabetes screening in Austria: a retrospective analysis of 3293 births. Arch Gynecol Obstet 2019; 299: 345-351
    CrossrefPubMedGoogle Scholar
  • 61 Pu J, Zhao B, Wang EJ. et al. Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors. Paediatr Perinat Epidemiol 2015; 29: 436-443
    CrossrefPubMedGoogle Scholar
  • 62 Seghieri G, Di Cianni G, Seghieri M. et al. Risk and adverse outcomes of gestational diabetes in migrants: A population cohort study. Diabetes Res Clin Pract 2020; 163: 108128
    CrossrefPubMedGoogle Scholar
  • 63 Carolan M, Gill GK, Steele C. Women’s experiences of factors that facilitate or inhibit gestational diabetes self-management. BMC Pregnancy Childbirth 2012; 12: 99
    CrossrefPubMedGoogle Scholar
  • 64 El-Khoury Lesueur F, Sutter-Dallay AL, Panico L. et al. The perinatal health of immigrant women in France: a nationally representative study. Int J Public Health 2018; 63: 1027-1036
    CrossrefPubMedGoogle Scholar
  • 65 Eggemoen AR, Wiegels Waage C, Sletner L. et al. Vitamin D, Gestational Diabetes and Measures of Glucose Metabolism in a Population-Based Multiethnic Cohort. J Diabetes Res 2018; 2018: 8939235
    CrossrefPubMedGoogle Scholar
  • 66 Ziegler AG, Wallner M, Kaiser I. et al. Long-Term Protective Effect of Lactation on the Development of Type 2 Diabetes in Women with Recent Gestational Diabetes Mellitus. Diabetes 2012; 61: 3167-3171
    CrossrefPubMedGoogle Scholar
  • 67 Lange C, Schenk L, Bergmann R. Verbreitung, Dauer und zeitlicher Trend des Stillens in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl 2007; 50: 624-633
    CrossrefPubMedGoogle Scholar
  • 68 Shane AL. Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues. Emerg Infect Dis 2014; 20: 1961
    CrossrefPubMedGoogle Scholar
  • 69 Berger F. Diabetes und Schwangerschaft bei Migrantinnen. In: Stupin JH, Schäfer-Graf U, Hummel M Diabetes in der Schwangerschaft. Berlin: de Gruyter; 2020: 301-310
    CrossrefGoogle Scholar
  • 70 Statistik Austria: Österreichische Gesundheitsbefragung 2019. Bundesministerium für Soziales, Gesundheit, Pflege und Konsumentenschutz (BMSGPK). Wien; 2020
    PubMed
  • 71 Global action plan for the prevention and control of noncommunicable diseases. Geneva: WHO; 2013. Received from: http://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf;jsessionid=AABE03207E539F6D022B9C096CDDB5C8?sequence=1
    PubMed
  • 72 World Health Organization (WHO): Obesity and Overweight: Fact sheet N 311. Geneva: WHO; 2021. Received from: https://www.who.int/newsroom/fact-sheets/detail/obesity-and-overweight
    PubMed
  • 73 The challenge of obesity in the WHO European Region and the strategies for response. Summary. Copenhagen: WHO; 2007. Received from: https://www.euro.who.int/__data/assets/pdf_file/0008/98243/E89858.pdf
    PubMed
  • 74 Koletzko B, Godfrey KM, Poston L. et al. Nutrition during pregnancy, lactation and early childhood and its implications for maternal and longterm child health: The Early Nutrition Project recommendations. Ann Nutr Metab 2019; 74: 93-106
    CrossrefPubMedGoogle Scholar
  • 75 Dietrich S, Phillipp K, Widhalm K. Das HELENA Projekt. Journal für Ernährungsmedizin 2007; 9: 19-21
    PubMedGoogle Scholar
  • 76 Strauss RS. Childhood obesity and self-esteem. Pediatrics 2000; 105: e15
    CrossrefPubMedGoogle Scholar
  • 77 Segna D, Widhalm H, Pandey MP. et al. Impact of mother tongue and gender on overweight, obesity and extreme obesity in 24,989 Viennese children/adolescents (2-16 years). Wien Klin Wochenschr 2012; 124: 782-788
    CrossrefPubMedGoogle Scholar
  • 78 Will B, Zeeb H, Baune BT. Overweight and obesity at school entry among migrant and German children: a cross-sectional study. BMC Public Health 2005; 9: 45
    CrossrefPubMedGoogle Scholar
  • 79 Kobel S, Kettner S, Hermeling L. et al. Objectively assessed physical activity and weight status of primary school children in Germany with and without migration backgrounds. Public Health 2019; 173: 75-82
    CrossrefPubMedGoogle Scholar
  • 80 Schlaud M. Der Kinder- und Jugendgesundheitssurvey (KiGGS): Datengrundlage für eine evidenzbasierte Prävention. Public Health Forum 2010; 18: 7-8
    CrossrefPubMedGoogle Scholar
  • 81 Fismen AS, Buoncristiano M, Williams J. et al. Socioeconomic differences in food habits among 6- to 9-year-old children from 23 countries-WHO European Childhood Obesity Surveillance Initiative (COSI 2015/2017). Obes Rev 2021; 22: e13211
    CrossrefPubMedGoogle Scholar
  • 82 Ernst JB, Arens-Azevêdo U, Bitzer B et al. für Deutsche Adipositas-Gesellschaft, Deutsche Diabetes Gesellschaft und Deutsche Gesellschaft für Ernährung. Quantitative Empfehlung zur Zuckerzufuhr in Deutschland. Bonn; 2018
    PubMed
  • 83 Knowler WC, Barrett-Connor E, Fowler SE. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002; 346: 393-403
    CrossrefPubMedGoogle Scholar
  • 84 Landgraf R, Heinemann L, Schleicher E. et al. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022. Diabetologie 2022; 17: S98-S110
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke DIfE – DEUTSCHER DIABETES-RISIKO-TEST. Diabetologie 2022; 17: S441-S444
    Article in Thieme ConnectPubMedGoogle Scholar
  • 86 FINDRISK – Test für Diabetesrisiko Diabetologie 2022; 17: S437-S439
    Article in Thieme ConnectPubMed
  • 87 BGBL. Gesetz zur Stärkung der Gesundheitsförderung und der Prävention vom 17. Juli 2015. Sect. Bundesgesetzblatt Jahrgang 2015 Teil I Nr.31.
    PubMed
  • 88 Knowler WC, Fowler SE, Hamman RF. Diabetes Prevention Program Research Group; Knowler WC et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-1686
    CrossrefPubMedGoogle Scholar
  • 89 Jager MJ, van der Sande R, Essink-Bot ML. et al. Views and experiences of ethnic minority diabetes patients on dietetic care in the Netherlands – a qualitative study. Eur J Public Health 2019; 29: 208-213
    CrossrefPubMedGoogle Scholar
  • 90 Sacks FM, Bray GA, Carey VJ. et al. Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates. N Eng J Med 2009; 360: 859-873
    CrossrefPubMedGoogle Scholar
  • 91 Hooper L, Summerbell CD, Thompson R. et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2011; CD002137
    PubMedGoogle Scholar
  • 92 Heidemann C, Hoffmann K, Spranger J. et al. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC) – Potsdam Study cohort. Diabetologia 2005; 48: 1126-1134
    CrossrefPubMedGoogle Scholar
  • 93 Hassanein M, Al-Arouij M, Hamdy O. et al. Diabetes and Ramadan: Practical guidelines. Diabetes Res Clin Pract 2017; 126: 303-316
    CrossrefPubMedGoogle Scholar
  • 94 International Diabetes Federation (IDF) and the Diabetes and Ramadan DAR International Alliance. Practical Guidelines. Brussels, Belgium: International Diabetes Federation; 2016: 108-114. Received from: www.idf.org/guidelines/diabetes-in-ramadan; Accessed 25.07.2019
    PubMed
  • 95 Babineaux SM, Toaima D, Boye KS. et al. Multi-country retrospective observational study of management and outcomes of patients with type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 2015; 32: 819-828
    CrossrefPubMedGoogle Scholar
  • 96 Salti I, Bénard E, Detournay B. et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27: 2306-2311
    CrossrefPubMedGoogle Scholar
  • 97 Shiju R, Akhil A, Thankachan S. et al. Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis. J Diabetes Res 2022; 2022: 3846253
    CrossrefPubMedGoogle Scholar
  • 98 Azis KMA. Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients. Diabetes Metab Synd. Obes 2015; 16: 207-211
    PubMedGoogle Scholar
  • 99 Salem BA, Farooqi MH, Suliman SG. et al. Use of Sodium-Glucose Co-Transporter 2 Inhibitors during de Fasting of Ramadan: Is there cause for concern?. Ibnosina J Med Biomed Sci 2015; 8: 81-88
    PubMedGoogle Scholar
  • 100 Ali S, Davies MJ, Brady EM. et al. Guidelines for managing diabetes in Ramadan. Diabet Med 2016; 33: 1315-1329
    CrossrefPubMedGoogle Scholar
  • 101 Ibrahim M, Davies MJ, Ahmad E. et al. Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. BMJ Open Diabetes Res Care 2020; 8: e001248
    CrossrefPubMedGoogle Scholar
  • 102 Loh HH, Yee A, Loh HS. et al. Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and metaanalysis. Prim Care Diabetes 2016; 10: 210-219
    CrossrefPubMedGoogle Scholar